Regina Schaffer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Regina schaffer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Regina Schaffer Today - Breaking & Trending Today

Navigating menopausal hormone therapy as CVD risk grows requires 'nuanced approach'

Navigating menopausal hormone therapy as CVD risk grows requires 'nuanced approach'
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United States , San Diego , Michael Honigberg , Cynthiaa Stuenkel , Joann Manson , Joanne Manson , Regina Schaffer , Richard Smith , Gina Lundberg , Byregina Schaffer , Leslie Cho , Cleveland Clinic Women Cardiovascular Center , Harvard Medical School , Emory University School Of Medicine , Emory Women Heart Center , Cardiovascular Disease In Women Committee Cho , Menopause Society , Endocrine Society , Women Health Initiative , University Of California , American Association Of Clinical Endocrinology , American College Of Obstetricians , Wear Red Day , Healio Exclusive , Women Committee , Health Initiative ,

Women with atherosclerotic CVD aren't taking statins as often as men. Why?

Women with atherosclerotic CVD aren't taking statins as often as men. Why?
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Amit Khera , Rina Mauricio , Kevinc Maki , Fatima Rodriguez , Regina Schaffer , Alexander Turchin , Byregina Schaffer , Richard Smith , Erind Michos , Ut Southwestern Medical Center , National Lipid Association , Harvard Medical School , Stanford University , Ut Southwestern Preventive Cardiology Program , Johns Hopkins Ciccarone Center , Indiana University School Of Public Health , Midwest Biomedical Research , Healio Exclusive , Indiana University School , Public Health , National Lipid , Cardiology Today Editorial Board Member Erin , Cardiovascular Disease , Medical Center , Preventive Cardiology Program ,

'Game changing' data: New obesity drugs tied to major weight loss, may reduce CV risk

'Game changing' data: New obesity drugs tied to major weight loss, may reduce CV risk
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Byregina Schaffer , Stevenb Heymsfield , Aniam Jastreboff , Zealand Pharma , Fatima Rodriguez , Versanis Bio , Carel Le Roux , Eli Lilly , Regina Schaffer , Richard Smith , Le Roux , Ianj Neeland , Survodutide Boehringer Ingelheim , Ttirzepatide Mounjaro , Samuele Crockett , Richarde Pratley , Ania Jastreboff , Novo Nordisk , Wake Forest School Of Medicine , Stanford University , Yale Center , Boehringer Ingelheim , University College Dublin , Weight Management Center , Yale Stress Center , Case Western Reserve University School Of Medicine ,

Bempedoic acid an 'effective alternative' for statin-intolerant patients: CLEAR Outcomes

NEW ORLEANS — In the CLEAR Outcomes trial, bempedoic acid reduced risk for major CV events by 13% compared with placebo, including a 23% lower risk for MI, among adults with a history of CVD or at high risk deemed statin intolerant.Bempedoic acid (Nexletol, Esperion Therapeutics) was FDA approved in 2020 for lowering LDL, but the effects of the drug on CV outcomes have not been assessed, ....

United States , Katie Kalvaitis , Stevene Nissen , Eli Lilly , Johnf Keaney Jr , Regina Schaffer , Patricia Dickey , Johnh Alexander , Howard Weintraub , Byregina Schaffer , Duke University School Of Medicine , Duke Clinical Research Institute , University Of Massachusetts Medical School In Worcester , Convention Center Bempedoic , American College Of Cardiology Scientific Session , Vascular Thoracic Institute , Bristol Myers Squibb , American College , Cardiology Late Breaking Clinical , Cardiology Scientific Session , New Orleans , Esperion Therapeutics , Arnold Miller Family Heart , Thoracic Institute , Patricia Dickey Chair , Cardiovascular Medicine ,

In type 2 diabetes, 'something brain-friendly' about GLP-1 receptor agonists

PHILADELPHIA — Diabetes independently increases risk for cognitive decline, yet data from several large trials suggest GLP-1 receptor agonists hold significant promise to mitigate risk for dementia-related events, according to a speaker.
“In addition to age and other risk factors, diabetes is a risk factor for cognitive decline, as is the degree of hyperglycemia,” Hertzel C. ....

United States , Hertzelc Gerstein , Eli Lilly , Regina Schaffer , Mcmaster University , Hamilton Health Sciences In Ontario , Boehringer Ingelheim , Novo Nordisk , Hamilton Health Sciences , Lancet Neurology ,